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-NC-ND license (http://creativecomCoronavirus disease 2019 (COVID-19) is a highly infectious
disease that originated in Wuhan, China and is now
spreading throughout the world.1,2 A couple of weeks prior
to the COVID-19 outbreak in Iran, the number of patients
referred to our gastroenterology clinic in Shahid Beheshti
Hospital in Qom increased unusually by 20%. The patients
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mons.org/licenses/by-nc-nd/4.0/exhibited various gastrointestinal (GI) symptoms, including
epigastric pain, constipation, diarrhea, nausea, vomiting,
muscle pain, and melena; the patients did not respond to
treatment with common therapeutic agents. Following
history-taking and physical examination, appropriate
biochemical, hormonal, and blood and tumor marker tests
were conducted. However, the persistence of clinical
symptoms led us to conduct other diagnostic procedures
such as abdominopelvic computed tomography (CT),
endoscopy, and colonoscopy. For the majority of patients,
results of laboratory tests for blood analysis, biochemical
analyses, endoscopy, and colonoscopy were acceptable.
However, some abnormal findings were noted in the upperby Elsevier Taiwan LLC. This is an open access article under the CC
).
COVID-19 exists in unusual GI symptoms? 385abdominal CT scan sections. Due to the current outbreak of
COVID-19 in Qom province, we immediately suspected
COVID-19. For further evaluation, a chest CT scan and
laboratory tests for SARS-CoV-2 were performed using real-
time reverse-transcriptase polymerase chain reaction (rRT-
PCR). Surprisingly, all patients with unusual GI symptoms,
tested positive for SARS-CoV-2 and various forms of lung
involvement were seen in the chest CT scans. However, no
mortality occurred and all symptoms subsided after 2e3
weeks for all patients, without the administration of any
medication. Respiratory tract symptoms were not observed
in any patient in this study.
Based on these findings, we hypothesized that COVID-19
has a spectra of symptoms, and unusual GI symptoms can be
considered among them. Lai et al.,3 have reported that in
adult patients, fever was the most common symptom
(92.8%; n Z 258), followed by cough (69.8%; n Z 194),
dyspnea (34.5%; n Z 96), myalgia (27.7%; n Z 77), head-
ache (7.2%; n Z 20), and diarrhea (6.1%; n Z 17).3 Our
observations are based on patients referred to a single-
center gastroenterology clinic, and only two cases were
documented. Thus, it is important to address promptly
whether the incidence of unusual GI symptoms occurs
before the incidence of respiratory disorders in patients
confirmed to have COVID-19 pneumonia. The answer to this
question may offer better, more effective therapeuticmanagement, before lung involvement, of the COVID-19
virus.
In conclusion, all physicians should be aware of some
unusual GI symptoms, which could be initial symptoms in
patients suspected of COVID-19. Moreover, it is necessary to
take precautions to avoid spread of this highly contagious
infection, especially to those who are in close contact with
the patient.
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